Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IronMan: Deferiprone and N-Acetylcysteine for Negative Symptoms in Schizophrenia
NCT07759895Phase 2Recruiting
- Sponsor
- Nidaria Technology
- Start
- Aug 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of deferiprone in schizophrenia, schizoaffective disorder, sponsored by Nidaria Technology. Started Aug 2026; status: recruiting.
02
Drugs
deferiprone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT07759895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07759895.